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Abstract: A novel flow injection chemiluminescence (CL) method for the determination of loxoprofen and naproxen was
proposed based on the CL system of KMnO, and Na,SOJ in acid media. The CL intensity of KMnO,-Na,SOJ was greatly
enhanced in the presence of loxoprofen and naproxen. The mechanism of the CL reaction was studied by the kinetic
process and UV-vis absorption and the conditions were optimized. Under optimized conditions, the CL intensity was
linear with loxoprofen and naproxen concentration in the range of 7.0 X 10- 8 -1. 0 x 10- 5 glmL and 2.0 x 10- 7 - 4.0 X 10-·
glmL with the detection limit of 2.0 x 10- 8 glmL and 3.0 x 10- 8 glmL (SIN = 3), respectively. The relative standard
deviations were 2.39% and 1.37% for 5.0 x 10- 7 glmL naproxen and 5.0 x 10- 7 glmL loxoprofen (n = 10), respectively.
The proposed method was satisfactorily applied to the determination of loxoprofen and naproxen in pharmaceutical prepa-
rations.
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1 Introduction
Nonsteroidal anti-inflammatory drugs (NSAIDs) are a
group of analgesics and anti-inflammatory drugs that are
most commonly used around the world for treating inflam-
matory diseases and musculoskeletal injuries for their anal-
gesic and antipyretic effects. Recently, NSAIDs have
gained more attention because they can reduce the risk of
developing Alzheimer's disease and various tumors [1-5].
NSAIDs are a large family of compounds according to their
chemical structures. Regardless of their structural differ-
ences, NSAIDs induce mostly of the same therapeutic func-
tions as well as side effects [6].
Loxoprofen and naproxen are well-established NSAIDs
which belong to the arylpropionic acid family, the struc-
tures as described in Figure 1. The two arylpropionic acid
derivatives have been used widely in clinic and other fields.
Up to now, many researchers interested in their possible
side effects considerably. At the same time, these com-
pounds are environmental pollutants due to their residue
levels in water [7, 8]. Therefore, it is very important to
develop highly sensitive analytical methods for the analysis
of loxoprofen and naproxen. Many methods have been
developed for the assay of loxoprofen and naproxen, inclu-
ding spectrometry [9, 10], HPLC [11-13]' HPLC- MS [14-
16], CE [17,18], and GC- MS [19,20]. Some of methods,
however, have shown considerable shortcomings, such as
bulky instrumentation, large sample, and time consump-
tion.
Chemiluminescence (CL) is a simple and rapid method
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which does not require sophisticated instruments and too
many chemical reagents. CL method has been developed to
detect arylpropionic acid derivatives, such as ketoprofen,
naproxen, ibuprofen, and fenbufen [21-25]. To the best of
our knowledge, CL method for the detection of loxoprofen
has not been reported.
In this paper, a novel flow injection chemiluminescence
method for the determination of loxoprofen and naproxen
is proposed based on the CL reaction of KMn04 and
NazSQ in acid media. The CL intensity of KMnO,-NazSQ
was greatly enhanced in the presence of loxoprofen and
naproxen. The mechanism of the CL reaction was studied
and the conditions were optimized. The proposed method
was applied to the determination of loxoprofen and naproxen
in pharmaceutical preparations.
2 Materials and methods
2.1 Reagents
The stock solutions (1.0 x 10- 3 glmL) of loxoprofen and
naproxen (National Institute for the Control of Pharmaceu-
tical and Biological Products, Beijing, China) were pre-
pared by dissolving 0.1000 g of each compound in double
distilled water and diluting to 100 mL. The stock solutions
were stored in a refrigerator and kept from light. The tes-
ting solutions were prepared by appropriate dilution of these
stock solutions with water before use.
KMn04 stock solution (0.01 M) was prepared by dissol-
ving 0.1580 g of KMn04(Xi'an Chemical Reagent Factory,
Xi'an, China) in a 0.1 M sulfuric acid solution and diluting
to 100 mL with water. A NazSQ stock solution (5 x 10- 3
M) was prepared by dissolving 0.0630 g of sodium sulfite
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(Xi'an Chemical Reagent Factory, Xi'an, China) in water
and diluting to 100 mL with water. The working solutions
were obtained by a series of dilutions of the stock solution
with water.
All chemicals used were of analytical grade. Double dis-
tilled water was used during the entire experiment procedure.
Naproxen tablets (250 mg/ tablet) were provided by
Shaanxi LanHuaQiFoShan Pharmaceutical Co., Ltd.
(Shaanxi, China). Loxoprofen sodium capsules (60 mg/cap-
sule) were provided by Shandong Qidu Pharmaceutical Co.,
Ltd. (Shandong, China).
Ten capsules (tablets) of loxoprofen and naproxen were
accurately weighed, and then ground to fine powder,
respectively. A tablet sample equivalent to approximately
250 mg naproxen and 60 mg loxoprofen was weighed accu-
rately, and then dissolved in water. Each solution was fil-
tered and the corresponding residue was washed several
times with water. All the solutions were collected. When
the level of loxoprofen and naproxen was obove the cali-
bration ranges, samples were appropriately diluted with
water prior to the assay.
Figure 1 Structures of loxoprofen
and naproxen
4-(6-methoxy-2-naphthy 1)-2-butanone
Lexoprofen
(+)-2-(6-methoxy-2-naphthy I) propionic acid
Naproxen
P,
2.2 Apparatus
Figure 2 is the schematic diagram of the flow injection CL
(FI-CL) system. A peristaltic pump was used for delivering
the sample solution and NazSOJ solution. Another peristal-
tic pump was applied to deliver KMn04 solution. All com-
ponents were connected with PTFE tubing (0.8 mm i. d.)
in the flow system. Reagent solutions were injected into the
flow system by a six-way injection valve. A photomultiplier
tube was employed to detect the CL intensity. The CL sig-
nal was recorded and treated using IFFM-E type data pro-
cessing system (Xi'an Remax Electronic Science-tech Co. ,
Ltd., China).
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tion was injected into the NazSOJ solution stream. The
stream was merged with KMn04 solution in the flow cell to
produce CL emission. The signal was recorded using a com-
patible computer connected to the PMT. The concentration
of sample was quantified by the increase of CL intensity,
calculated as tJ = 1 - 10 , where 1 is the net CL signal of
the system in the presence of sample and [0 is the CL inten-
sity of the system in the absence of sample.
3 Results and discussion
3.1 CL intensity-time profile
The CL kinetic characteristics of the KMnOr Naz SOJ-
sample system were investigated. The results are shown in
Figure 3 and Figure 4. The results showed that a strong
enhancement of the CL emission of the KMnOr Naz SOJ
reaction was observed in the presence of naproxen and lox-
oprofen respectively. Therefore, the addition of two kinds
of arylpropionic acid derivatives could facilitate the
KMnOrNazSOJ CL reaction and greatly enhance light
emission.
Figure 3 Kinetic CL intensity-time profile of KMnO.-NazSQ,-
naproxen reaction.
108
- _. KMnO,-Na,SO, reaction
............. KMnO,-Na,SO,-naproxen reaction
- KMnO,-naproxen reaction
6
Time(s)
42
1600
C 1400
~ 1200 \
.:: 1000 \
....J
U 800
.,
.::: 600
~ 400 \~ 200 \ ........
o 1.onn._;r;;.._......._...u:;;;...__A_..,J,;;"""'"....-_"'.=--=="'-'''''"'~
o
The UV spectrum was obtained using an UV-vis spectro-
photometer (Shanghai Spectrum Instruments Co., Ltd.,
China) .
2.3 Procedures
Figure 2 Schematic diagram of the Fl-CL system for the determina-
tion of naproxen and loxoprofen. a, sample solution; b, NazSo. solu-
tion; c, KMnO. solution; PI and Pz, peristaltic pump; V, six-way
valve; F, flow cell; PMT, photomultiplier tube; COM, computer;
W, waste solution.
As shown in Figure 2, flow lines were inserted into the
sample/standard solution, loxoprofen or naproxen solution,
NazSOJ solution and KMn04 solution, respectively. The
pump was started to wash the whole flow system until a
stable baseline was recorded. Then a sample/standard solu-
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3.2 Optimization of experimental conditions
3.2.1 Effect of instrumental parameters
The instrumental parameters, including the flow rate, the
ratio of peristaltic pump1 to peristaltic pump2 (Vj /V2),
and the length (~) from three ways "T" to the flow cell,
were optimized. The length (~) of 6 cm and the flow rate
of 1.6 mUmin could give a steady baseline and the maxi-
mum CL intensity, which were chosen for further study.
added to the KMnO, solution to test the effect on the CL
signal. The maximum and most stable CL signal was
obtained when sulfuric acid was added. Hence, H2S04 was
chosen for further work. And then, the effect of H2S04
concentration on the CL intensity was studied over the
range of O. 01 M to O. 2 M. The results showed that the
maximum CL intensity was obtained with O. 1 M H2S04
(Figure 6). So, 0.1 M H2S04 was selected as the suitable
medium for subsequent work.
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Figure 4 Kinetic CL intensity- time profile of KMnO, -Naz SQ ·Ioxo-
profen reaction.
Figure 6 Effect of a so, concentration on the relative CL intensity.
1.0 x 10-' M KMnO, + 1. 0 X 10- 6 M naproxen + 5.0 X 10- 3 M
NazS0.J .
The effect of V j /V2 on the CL signal was investigated in
the range of 0.5 to 2, and the results showed that the maxi-
mum CL emission intensity was obtained when the ratio was
up to 1. 0 (as shown in Figure 5). Therefore, the ratio of
1. 0 was selected for subsequent procedures.
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Figure 5 Effect of V,/Vz ratio on the relative CL intensity. 1. 0 x
10-' M KMnO, (0.1 M a so, )+ 1. 0 X 10- 6 M naproxen + 5.0 X 10- 3
M NazS0.J.
In this CL system, potassium permanganate in sulfuric
acid which is used as the oxidant can offer both the maxi-
mum CL signal and the best signal to the background ratio.
Therefore, the effect of KMn04 concentration in 0.1 M
sulfuric acid medium on the relative CL intensity was stud-
ied in the range of 1. 0 x 10- 6 M to 1. 0 x 10-2M. The results
are shown in Figure 7. The results showed that 1. 0 x 10- 4 M
could give rise to the larger CL response and lower back-
ground signal. So, the optimum concentration of KMnO,
was chosen as 1. 0 x 10- 4 M. .
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Figure 7 Effect of KMnO, concentration on the relative CL intensity.
1.0 X 10- 6 M naproxen + 5.0 x 10- 3 M NazS0.J.
3.2.2 Effect of chemical variables
The chemical variables, including the concentrations of po-
tassium permanganate and sodium slufite, and the different
inorganic acid media, were investigated.
It was observed that the CL signal of KMnOr Na2SO:J
system was stronger in acid solution than in neutral or basic
solutions. Five different acids (i. e. HCI, HNO:J, Ha PO, ,
HAc, and H2S04 ) with different concentrations were
The effect of Na2SO:J concentration on the CL intensity
was investigated in the range of 1. 0 x 10 - 4 M to 1. 0 x 10- 2
M. The results are shown in Figure 8. The results showed
that the chemiluminescence intensity increased with the in-
crease of Na2 SO:J concentration when it was lower than 5.0
x 1O- 3 M, with a higher signal-to-noise ratio. Thus, 5.0 x
1O- 3 M was chosen for further study.
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3.3 Analytical characteristics
3.3.1 Linearity
Under the optimized conditions, the calibration curves for
the determination of naproxen and loxoprofen were estab-
lished by triplicate injections of different concentration
samples. The linear dynamic range, regression equation,
correlation coefficient, and limit of detection (WD) of
each compound are listed in Table 1.
Thble 1 The linear dynamic range, regression equation, correlation coefficient, and LOD of naproxen and loxoprofen
NSAIDs
Naproxen
Loxoprofen
Linear range (gimL)
7.0 x 10 8 - 1. 0 x 10 5
2.0XlO- 7 -4.0xlO- 8
Regression equation Correlation
(unit of C is f-lglmL) coefficient
M = 168. 58C + 44.6 0.9979
M = 58.6C+ 13.0 0.9958
LOD
(glmL)
2.0x 10 8
3.0X 10- 8
2 3 4 5 6 7 8 9 10 II
Na,SO, concentration (I O-'M)
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Figure 8 Effect of Nazso, concentration on the relative CL intensity.
LOX 1O-6M naproxen + LOX lO-'M KMnO, in 0.1 M HzSO, medium.
3.3.2 Precision
The precision of the proposed method was obtained by
analyzing samples containing 5.0 X 10- 7 glmL naproxen and
5.0 x 10-7 gI mL loxoprofen respectively. On three consecu-
tive days, each sample was injected ten times. The results
are listed in Table 2.
3.4 Analytical application
The proposed method was applied to the determination of
naproxen and loxoprofen in commercial pharmaceutical
formulations. The samples were determined by standard
addition method. As shown in Table 3, the obtained recov-
eries were in the range of 98.5% to 104.0%. As shown in
Table 4, the results showed that there were no significant
differences between the nominal content values and those
obtained by the proposed method.
Thble 3 Recovery rate of externally added (l x 1O-6g1mL) naproxen
and loxoprofen in pharmaceutical preparations
Original Added Found Recovery Average of
NSAlDs concentration concentration concentration rate recovery
(x 1O- 6g1mL) (x 1O- 6g1mL) (x 1O- 6g1mL) (%) rate (%)
0 0.97
Naproxen 1.0 1.0 1.99 102.0 101.82.0 3.03 103.0
3.0 3.98 100.3
0 0.95
Loxoprofen 1.0 1.0 1.99 104.0 100.62.0 2.92 98.5
3.0 3.93 99.3
Thble 2 The precision in the determination of naproxen and loxopro-
fen standard substance
NSAIDs
Naproxen
Loxoprofen
Concentration
(XlO- 7 glmL)
0.8
5.0
50
1.0
5.0
10
Concentration found
(x 10- 7 glmL)
0.81 ± 0.02
5.07±0.12
52.25±2.37
1.00±0.03
5.05±0.07
10.10±0.14
RSD
(%)
2.05
2.39
4.55
3.19
1.37
1.43
Thble 4 Analysis results of the two NSAIDs in pharmaceutical
preparations
NSAIDs pharmaceutical Nominal content Proposed FI-CL
preperation (gltablet) method (gltablet)
Naprofen tablets 0.25 0.23 ± O. 015
Loxoprofen tablets 0.060 0.058 ± O. 0014
Note: Values are the averages of three measurements ± SD (amount of
NSAIDs tablets [g! tablet]) .
3.3.3 Interference
In order to assess the analytical application possibility of the
CL method described above, the interference of different
metal ions and some excipients used in pharmaceutical prep-
arations on the CL intensity was investigated by analyzing
the solutions of 1.0 p.gImL naproxen and 1.0 p.gImL loxo-
profen, respectively. The tolerable limit of a foreign
species was taken as a relative error less than 5%. The
results showed that no interference could be observed when
the sample included up to a 1000-fold Mt + , ea2 + , Na+ ,
NOJ -, 100-fold Al3 +, starch, glucose, lO-fold COJ 2 - ,
sucrose, and uric acid.
3.5 Possible mechanism
Grinberg first used the potassium permanganate as the
chemiluminescence reagent in analytical chemistry in 1920.
And then, there are some discussions about the mechanism
of this kind of reaction and the corresponding emitting
species in the literature. The emitting species of the potassi-
um permanganate CL reaction can be broadly grouped as
follows: manganese species, singlet oxygen, analyte oxida-
tion products, and compounds that receive energy from an
excited intermediate of the reaction [26]. Excited sulphur
dioxide molecules are often considered as the CL emitters
when sodium sulfite reacts with potassium permanganate
[27]. Meixner and Jaeschke [28] proposed an alternative
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Figure 10 Absorption spectra of the KMn04 -N<l<!S0l-loxoproxen.
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